RSS Feeds

RSS Feed - Antitrust - Kaye Scholer LLP

Current Feed: http://www.kayescholer.com/practice/rss.xml?p=antitrust

Kaye Scholer Honored With 14 Practice and 48 Lawyer Rankings in Chambers USA 2013 (05/24/13)

Sam Lonergan concentrates his practice on complex commercial disputes with a particular focus on fraud and Deceptive Trade Practices Act (DTPA) matters and civil and criminal internal corporate investigations. He has litigated on behalf of clients in a wide range of industries, including pharmaceuticals, finance, telecommunications, aircraft and retail, always with a focus on providing practical advice that balances the client’s business needs with legal considerations.

Higgins, Jungermann, Mazur, Butler and Lanham Speak at the In-house Counsel Antitrust Update of the ABA Section of Antitrust Law – Corporate Counseling Committee (05/21/13)

Joseph Kohn (05/21/13)

Joseph Kohn is an Associate in the Litigation Department of Kaye Scholer’s New York office. Joseph’s recent experience includes the representation of a brand name pharmaceutical manufacturer in several federal and state class actions alleging claims of monopolization and conspiracy to restrain generic competition, as well as RICO violations. In Re Skelaxin (Metaxalone) Antitrust Litigation, MDL No. 2343. Joseph also represents companies within the Knauf Group in federal and state actions brought by thousands of homeowners who allegedly had defective Chinese-manufactured drywall in their homes. In Re Chinese-Manufactured Drywall Products Liability Litigation, MDL No. 2047.

Kenneth Maikish (05/20/13)

Kenneth Maikish’s practice focuses on intellectual property litigation, particularly patent litigation. Ken manages several patent litigation cases related to computer software. He has drafted Markman briefs and argued at a Markman hearing. Ken is responsible for all aspects of several patent cases including non-infringement theories, prior art research, invalidity theories, and discovery.

Daniel R. Paluch (05/17/13)

Daniel R. Paluch is a member of the firm’s Complex Commercial Litigation Department and IP and Technology Transactions Group. His areas of practice include intellectual property, antitrust, class actions, unfair competition and general business litigation. In addition to his work in litigation, Daniel has advised clients on technology transactions, including ERP, BPMS and SOA implementations, technology integration matters and open source licensing issues. He has also been actively involved in pro bono matters, representing several families who lost their homes to loan modification scams in the Los Angeles area. While at USC Law School, Daniel served on the staff of the Interdisciplinary Law Journal, was a teacher’s assistant for the law school’s Evidence, Professional Responsibility and Contracts courses and clerked for the Los Angeles County District Attorney’s Office.

Amanda L. Butler (05/16/13)

Amanda L. Butler is a litigation Associate in the Washington, DC office of Kaye Scholer. Since joining the firm, she has been actively involved in the firm’s Antitrust and Energy practices.

Joshua S. Stambaugh (05/14/13)

Josh Stambaugh is a member of the firm’s Complex Commercial Litigation Department with extensive experience assisting businesses of all size, from Fortune 500 companies to internet start-ups, in virtually area of commercial litigation, including: business litigation; interference claims; breach of contract; antitrust; unfair competition; misappropriation of trade secrets; fraudulent advertising; and class actions brought pursuant to consumer protection statutes. Josh has developed considerable knowledge of, and familiarity with, breach of contract, unfair competition, antitrust and consumer fraud class actions.

Bert L. Slonim (05/13/13)

Bert Slonim concentrates on complex commercial litigation, particularly multi-district pharmaceutical product liability cases. He has represented manufacturers of prescription drugs (including hormone replacement therapy, erectile dysfunction, diabetes, antibiotic, and anti-psychotic medications), implanted medical devices, agricultural chemicals, electrical equipment, aerospace products, asbestos and other products. Much of his practice focuses on developing and rebutting expert medical and scientific evidence, and litigating the admissibility of expert opinion testimony.